Top Stories
Top Stories
Wires

ROCHE HOLDING AG SAYS U.S. LIST PRICE FOR 4-MONTH COURSE OF POLIVY IS $90,000 ON AVERAGE; POLIVY DOSAGE BASED ON PATIENT WEIGHT